It is therefore necessary to understand the reasons for CD44+/CD24- breast cancer cells in bone: whether CTCs are CD44+/CD24- CSCs that preferentially migrate and establish metastases, or if non-CD44+/CD24- CTCs are induced to the CD44+/CD24- phenotype in the bone marrow. The gene discussed is CD44; the disease is breast carcinoma.